Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 719,000 | 2,853,000 | 3,148,000 | 2,632,000 | 2,166,000 |
| Marketable Securities | 11,209,000 | 9,837,000 | 41,033,000 | 42,153,000 | 17,806,000 |
| Receivables | 10,989,000 | 11,566,000 | 11,086,000 | 10,231,000 | 12,305,000 |
| Inventories | 10,892,000 | 10,189,000 | 10,204,000 | 10,310,000 | 9,541,000 |
| Other current assets | 8,606,000 | 8,888,000 | 8,541,000 | 8,021,000 | 8,260,000 |
| TOTAL | $42,415,000 | $43,333,000 | $74,012,000 | $73,347,000 | $50,078,000 |
| Non-Current Assets | |||||
| PPE Net | 18,803,000 | 18,940,000 | 17,862,000 | 17,488,000 | 17,052,000 |
| Investments And Advances | 11,613,000 | 15,368,000 | 14,239,000 | 15,066,000 | 14,743,000 |
| Intangibles | 132,126,000 | 132,683,000 | 91,751,000 | 92,978,000 | 93,478,000 |
| Other Non-Current Assets | 16,139,000 | 16,177,000 | 17,158,000 | 21,289,000 | 20,267,000 |
| TOTAL | $178,681,000 | $183,168,000 | $141,010,000 | $146,821,000 | $145,540,000 |
| Total Assets | $221,095,000 | $226,501,000 | $215,021,000 | $220,168,000 | $195,617,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,232,000 | 10,350,000 | 2,548,000 | 3,985,000 | 4,188,000 |
| Accounts payable and accrued liabilities | 5,591,000 | 6,710,000 | 5,338,000 | 6,081,000 | 6,123,000 |
| Accrued Expenses | 2,192,000 | 2,776,000 | 2,372,000 | 1,972,000 | 2,277,000 |
| Other current liabilities | 18,788,000 | 20,537,000 | 16,776,000 | 16,079,000 | 20,255,000 |
| TOTAL | $40,497,000 | $47,794,000 | $31,136,000 | $34,647,000 | $36,562,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,307,000 | 61,538,000 | 61,048,000 | 61,356,000 | 31,704,000 |
| Deferred Revenues | 2,502,000 | 2,700,000 | 2,204,000 | 1,286,000 | 1,750,000 |
| Other Non-Current Liabilities | 25,793,000 | 27,231,000 | 24,501,000 | 23,628,000 | 25,035,000 |
| TOTAL | $88,039,000 | $89,418,000 | $86,680,000 | $86,227,000 | $57,819,000 |
| Total Liabilities | $128,537,000 | $137,213,000 | $117,817,000 | $120,875,000 | $94,381,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,666,593 | 5,646,778 | 5,646,413 | 5,645,960 | 5,645,307 |
| Common Shares | 480,000 | 478,000 | 478,000 | 478,000 | 478,000 |
| Retained earnings | 121,318,000 | 118,353,000 | 126,411,000 | 128,796,000 | 131,102,000 |
| Other shareholders' equity | -7,482,000 | -7,687,000 | -7,696,000 | -7,828,000 | -8,024,000 |
| TOTAL | $92,558,000 | $89,288,000 | $97,204,000 | $99,293,000 | $101,236,000 |
| Total Liabilities And Equity | $221,095,000 | $226,501,000 | $215,021,000 | $220,168,000 | $195,617,000 |